Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

The Association Between High Risk Pregnancy and Sleep-disordered Breathing

30. november 2009 opdateret af: Assaf-Harofeh Medical Center
The aim of the present study is to establish, using polysomnographic criteria and prospective nature, whether sleep apnea in pregnancy is more prevalent in women with high risk pregnancies including preeclampsia, gestational diabetes, and pre-mature contractions, and to determine the effect of sleep disordered breathing in pregnancy on fetal outcome. The investigators' hypothesis is that sleep-disordered breathing is more prevalent in women with high risk pregnancy compared to those with uncomplicated pregnancy.

Studieoversigt

Detaljeret beskrivelse

Over the last decade, the association between sleep disordered breathing and pregnancy outcome has been described primarily in case reports. Although recently, larger studies describing adverse pregnancy outcomes in women with sleep disordered breathing has begun to emerge, these studies often lack polysomnographic data and the true prevalence of sleep disordered breathing in pregnancy is not known. We intend to recruit 100 women at the third trimester of pregnancy, who are admitted to the high risk pregnancy unit with pre-eclampsia, gestational diabetes, or premature labor. An additional group of 50 women at the third trimester of an uncomplicated pregnancy will be recruited. All women will fill questionnaires regarding the pregnancy and their sleep and will undergo an overnight sleep study. Women will then be followed until birth. Pregnancy complication, birth and perinatal course will be recorded. Cord blood will be collected from all infants and evaluated for inflammatory cytokines, reactive oxygen species and growth factors. Infants will then be followed for 1 year. Their growth, development and intercurrent illnesses will be recorded.

Undersøgelsestype

Observationel

Tilmelding (Forventet)

150

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

      • Kfar-Saba, Israel, 44281
        • Meir Hospital
      • Zerifin, Israel, 70300
        • Asaf Harofeh Medical Center

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

19 år til 39 år (Voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Kvinde

Prøveudtagningsmetode

Sandsynlighedsprøve

Studiebefolkning

Women in third trimester admitted to the high-risk pregnancy unit and women with uncomplicated pregnancy attending a pre-labor course

Beskrivelse

Inclusion Criteria:

  • Age 19 - 39 years
  • Over 26 weeks of gestation
  • One of the following:

    1. Pre-eclampsia defined as systolic blood pressure > 140 or diastolic blood pressure > 90 and associated proteinuria > 300 mg / 24 h urine collection.
    2. Gestational diabetes requiring insulin treatment
    3. Premature contractions with associated cervical dilation or effacement
    4. Uncomplicated pregnancy

Exclusion Criteria:

  • Chronic maternal disease
  • Alcohol consumption during pregnancy
  • Illicit drug abuse at any time in life
  • Fetal abnormalities on obstetric ultrasound

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

Kohorter og interventioner

Gruppe / kohorte
Premature labor
Women at the third trimester of pregnancy with premature contractions and cervical dilation of effacement
Control
Women at the third trimester of pregnancy with uncomplicated pregnancy
Pre-eclampsia
Women at the third trimester with pre-eclampsia
Gestational diabets
Women at the third trimester of pregnancy with gestational diabetes requiring insulin

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Tidsramme
apnea-hypopnea index
Tidsramme: At time of assessment
At time of assessment

Sekundære resultatmål

Resultatmål
Tidsramme
birth weight, apgar score
Tidsramme: at birth
at birth
inflammatory markers in cord blood
Tidsramme: at birth
at birth
growth and development during the 1st year of life
Tidsramme: at age 1 year
at age 1 year

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Samarbejdspartnere

Efterforskere

  • Ledende efterforsker: Isaac Shpirer, MD, Pulmonary division ans sleep laboratory, Asaf Harofeh Medical Center

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. januar 2010

Primær færdiggørelse (Forventet)

1. januar 2012

Datoer for studieregistrering

Først indsendt

26. november 2009

Først indsendt, der opfyldte QC-kriterier

30. november 2009

Først opslået (Skøn)

1. december 2009

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

1. december 2009

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

30. november 2009

Sidst verificeret

1. november 2009

Mere information

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

3
Abonner